Oncology & Cancer

Benefits of prostate-specific antigen testing remain unclear

(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, according to a provisional ...

Diseases, Conditions, Syndromes

45.4 percent of U.S. adults at risk for complications with COVID-19

(HealthDay)—An estimated 45.4 percent of U.S. adults may have an increased risk for COVID-19 complications due to chronic conditions, according to a study published in the August issue of Emerging Infectious Diseases.

Oncology & Cancer

ASCO: CRP predicts complications after esophagectomy

(HealthDay)—C-reactive protein (CRP) on postoperative day 4 (POD 4) after esophagectomy is associated with increased odds of serious infectious complications (SICs), according to a study presented at the American Society ...

page 1 from 3